Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
Top Cited Papers
- 1 May 2004
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (7), 939-950
- https://doi.org/10.1016/j.ejca.2003.12.004
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Mutational Analysis of the Human Dihydropyrimidine Dehydrogenase Gene by Denaturing High-Performance Liquid ChromatographyGenetic Testing, 2003
- Dihydropyrimidine dehydrogenase circadian rhythm in mouse liverEuropean Journal Of Cancer, 2003
- Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancerJournal of Surgical Oncology, 2002
- Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controlsZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Relationship between Protein Levels and Gene Expression of Dihydropyrimidine Dehydrogenase in Human Tumor Cells during Growth in Culture and in Nude MiceJapanese Journal of Cancer Research, 1998
- A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1996
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Do antimetabolites interfere with the glycosylation of cellular glycoconjugates?European Journal of Cancer and Clinical Oncology, 1990
- The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cellsBiochemical and Biophysical Research Communications, 1985